Press Releases

Stanford Medicine investigators and their collaborators have designed a compound that’s uniquely capable of blocking excessive mucus secretion — a hallmark of several serious respiratory disorders.

The structure of a critical cellular-signaling molecule has finally been discovered by Stanford researchers. The finding may lead to new therapies.

Stanford Medicine researchers have linked a specific gene known to be associated with ALS with a characteristic of the disease, opening avenues for a targeted therapy.

Veterans taken by ambulance to VA hospitals have significantly higher survival rates than veterans transported to non-VA hospitals, researchers find.

Girls with autism differ in several brain centers compared with boys with the disorder, suggesting gender-specific diagnostics are needed, a Stanford study using artificial intelligence found.

The Stanford pediatric radiologist, after noticing a new and disturbing pattern among lung X-rays of premature infants, forever altered treatment for the smallest babies.

COVID-19 vaccines are better than infection at making antibodies to recognize new viral variants, according to a Stanford study.

A new study found that part of the Epstein-Barr virus mimics a protein made in the brain and spinal cord, leading the immune system to mistakenly attack the body’s nerve cells.

A look at antibodies in patients soon after they were infected with the virus that causes COVID-19 showed key differences between those whose cases remained mild and those who later developed severe symptoms.

Deerfield Management, a health care investment firm, has committed up to $130 million to support innovative translational research at Stanford.